Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10330600
Plasmonic-magnetic bifunctional nanotubes for biological applications
granted -
US 10328139
Live-attenuated vaccine against plague
granted -
US 10323070
VMP-like sequences of pathogenic Borrelia species and strains
granted -
US 10322069
Restorative resin compositions and methods of use
granted -
US 10322113
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same
granted -
US 10322171
Vaccine with reduced enhancement of viral infection
granted -
US 10314950
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 10316073
FCRN antagonists and methods of use
granted -
US 10300106
Autophagy-inducing peptide analogs
granted -
US 10300151
Methods and systems for noninvasive fluorescence-based functional imaging of kidneys
granted -
US 10301320
Compositions and methods of modulating 15-PGDH activity
granted -
US 10292986
Methods for treating epithelian mesenchymal transition related diseases
granted -
US 10293022
Peptide inhibitors of serotonin 5-HT2C receptor:PTEN interaction
granted -
US 10293056
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
granted -
US 10293002
Methods and compositions for in vivo induction of pancreatic beta cell formation
granted -
US 10287584
Compounds and methods for the modulation of COMP
granted -
US 10286065
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
granted -
US 10285945
Formation of stable submicron peptide or protein particles by thin film freezing
granted -
US 10285956
N-(2-aminoethyl) ethanolamine (AEEA) and analogs to treat hypertrophic scarring and liposomal topical delivery
granted -
US 10285986
Compounds and anti-tumor NQO1 substrates
granted -
US 10287262
Eicosanoid derivatives
granted -
US 10280171
Heterocyclic inhibitors of PTPN11
granted -
US 10279042
One-step processing of hydrogels for mechanically robust and chemically desired features
granted -
US 10279029
Immunogenic compositions and uses thereof
granted